Project Grant R01AI184466
Award Date
3/19/25
Completion Date
2/28/30
Dollars Obligated
$639K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $693,465 to Cornell University to conduct research on mapping the development of T cell immunity in lymph nodes from infancy to adulthood. The key objectives are to:
Determine how the spatial organization of T cells changes in the lymph node throughout childhood.
Examine how the lymph node shapes the CD8+ T cell response to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $195,068 to Yale University to conduct research on the unique features and functionality of CD8 T cells in early childhood. The key objectives are to:
Define the mechanisms driving increased proliferation, glycolysis, and cell death in CD8 T cells from neonates and young children compared to adults.
Determine the role of PI3K/mTOR...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $483,194 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The funding will support a 5-year project to define the protective CD4+ T cell signature that drives effective CD8+ T cell immunity against hepatitis C virus (HCV) infection. The project will leverage historical blood and liver samples from...
This federal Project Grant award of $534,000.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at The Children's Hospital of Philadelphia (CHOP) to investigate the mechanisms driving CD4+ T cell differentiation and functionality.
The research aims to elucidate how the location and density/half-life of peptide-MHC II complexes on antigen-presenting cells (a "potent Signal 1") can influence the...
This federal Project Grant award, with ID R01AI179712, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855).
The approximately $857,346 award will fund research by the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) to investigate how activating and inhibitory signals in the form of cytokines and metabolites present in healthy human tissues regulate the effector...
This $1,156,161 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to understand the biological mechanisms that govern CD8 T cell activity and differentiation into resident memory cells (TRM) within the female reproductive tract (FRT). The project aims to leverage a 3D organoid system to rapidly identify transcriptional regulators and signaling pathways, such as the role of retinoic...
This federal Project Grant award in the amount of $1,179,316.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award is focused on understanding the mechanisms that regulate CD8 T cell responses during chronic viral infection, with the goal of improving immunotherapies to increase T cell function and reduce viral load. Key aspects of the research include:
Determining the role of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $448,765 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Oregon Health & Science University (OHSU) to study the persistence of HIV-specific CD8+ T cell responses in early-treated Thai children on long-term antiretroviral therapy (ART). The key objectives are to: 1) Determine the magnitude, phenotype, and functionality of HIV-specific CD8+ T cells that persist in early-treated children...
This $781,685 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the molecular circuits that control the development of human T follicular regulatory (Tfr) cells and their role in common variable immunodeficiency (CVID) pathogenesis. The research aims to establish how natural Tfr (nTfr) and induced Tfr (iTfr) cell subsets are clonally distinguished and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to support high-throughput discovery of novel transcriptional programs regulating T cell exhaustion. The $450,526 grant awarded to Northwestern University will leverage recently developed single-cell sequencing and CRISPR/Cas9 gene editing technologies to rapidly screen and validate the function of transcription factors that govern the...